Detects region-specific metabolic changes in MRI-negative, 18FDG-PET-positive epilepsy patients, suggesting a new diagnostic tool.
Objective Identifying presumed epileptogenic region (PER) in MRI-negative epilepsy patients is crucial for successful surgical outcomes.This study aims to determine whether dynamic deuterium metabolic imaging (DMI) at 7Tesla can detect region-specific metabolic alterations in MRI-negative, 18 FDG-PET-positive temporal-lobe epilepsy.
No takes yet. Share an insight, caveat, or question.
Ahmadian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: